logo
搜索
菜单

Cytotoxici的搜索结果

当前1/2页
排序: 总浏览数
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay 10.3791/50767-v 11:14 min
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Cellular Toxicity of Nanogenomedicine in MCF-7 Cell Line: MTT assay 10.3791/1191-v 19:34 min
Cellular Toxicity of Nanogenomedicine in MCF-7 Cell Line: MTT assay
Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System 10.3791/3683-v
Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System
Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System 10.3791/3683-v
Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System
A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity 10.3791/56191-v 06:08 min
A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity
An Automated Method to Perform The In Vitro Micronucleus Assay using Multispectral Imaging Flow Cytometry 10.3791/59324-v
An Automated Method to Perform The In Vitro Micronucleus Assay using Multispectral Imaging Flow Cytometry
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors 10.3791/51400-v
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis 10.3791/55542-v 07:25 min
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
A Spheroid Killing Assay by CAR T Cells 10.3791/58785-v 08:19 min
A Spheroid Killing Assay by CAR T Cells
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells 10.3791/54078-v 09:39 min
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells 10.3791/50058-v 09:28 min
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models 10.3791/54714-v 09:58 min
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes 10.3791/2724-v 12:12 min
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs 10.3791/2460-v
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
High-throughput Titration of Luciferase-expressing Recombinant Viruses 10.3791/51890-v
High-throughput Titration of Luciferase-expressing Recombinant Viruses
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291 10.3791/54850-v 06:51 min
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro 10.3791/51213-v 08:04 min
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Flow Cytometric Analysis of Natural Killer Cell Lytic Activity in Human Whole Blood 10.3791/54779-v 08:14 min
Flow Cytometric Analysis of Natural Killer Cell Lytic Activity in Human Whole Blood
High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC) 10.3791/53987-v
High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Real-time Cytotoxicity Assays in Human Whole Blood 10.3791/51941-v 08:27 min
Real-time Cytotoxicity Assays in Human Whole Blood
返回顶部